Company profile

Imagen Technologies, Inc

Medical Imaging & Radiology

Company profile

About Imagen Technologies, Inc

Imagen Technologies, Inc. is transforming diagnostic imaging by creating a new standard of care that combines first-of-its-kind AI technology with world-class clinical expertise. The company provides comprehensive diagnostic imaging solutions including permanent in-office imaging equipment and programs, AI-enabled sub-specialized specialist interpretations by U.S.-based board-certified radiologists, and advanced imaging analytics (RadGap) to help payers, providers, and risk-bearing entities close care gaps. Founded by CEO Alex Dresner based on personal experiences with diagnostic imaging error, Imagen's mission is to ensure every patient receives the right diagnosis at the right time. The company operates across 23 states with radiologist licenses in all 50 states, serving 3.5 million patients through 200+ clinic locations. Their vertically integrated approach combines FDA-cleared deep-learning-based Computer Assisted Detection software with 95+ board-certified specialists and sub-specialists, delivering 24/7 high-quality teleradiology support. Imagen's proprietary AI technology has demonstrated significant clinical impact, including a 73% reduction in life-threatening clinical misses and 100% increase in appropriate chronic disease identification. The company maintains a 97% all-time customer retention rate and 95% physician recommendation rate, reflecting their commitment to partnership and quality. Their technology is built on one of the largest medical imaging datasets in the world, with tens of millions of images, and has undergone rigorous FDA evaluation and peer-reviewed publication in journals such as PNAS and Nature Digital Medicine.

Company description Imagen Technologies, Inc official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Imagen Technologies, Inc?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • chest imaging findings
  • chronic disease
  • life-threatening conditions

Who it serves

  • Health systems
  • Hospitals
  • Independent practices
  • Payers
  • Risk-bearing entities

Deployment & integration

Cloud Saas · Embedded · On Premise deployment with recorded integration context.

Recorded integration context: EMR systems.

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

Operating in 23 states, serving 3.5 million patients through 200+ clinic locations, 1.3 million+ run-rate annual diagnostic results provided, radiologist licenses across all 50 states

Partnerships

Recorded partners

No partners are currently listed.

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Advanced Imaging Analytics (RadGap)

AI-enabled image and report analytics to help close care gaps

Software · Cloud SaaSCompany source

AI Software (Chest-CAD)

FDA-cleared AI algorithms to support diagnostic specialists

Software · EmbeddedCompany source

AI Software (Computer Assisted Detection)

FDA-cleared AI algorithms for enhanced diagnostic accuracy

Software · EmbeddedCompany source

AI-Enabled Sub-specialized Specialist Interpretations

U.S.-based, board-certified specialists enabled with cutting-edge AI for improved accuracy

Service · Cloud SaaSCompany source

In-Clinic Imaging

Permanent, in-office imaging equipment and programs with end-to-end support

Service · On PremiseCompany source

RadGap - Advanced Imaging Analytics

AI-enabled image and report analytics that help close care gaps

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

No linked records are currently available.

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

Lung-CAD

K230085 · 510k · Oct 3, 2023

Lung-CAD

K223811 · 510k · Sep 13, 2023

Aorta-CAD

K213353 · 510k · Sep 20, 2022

Chest-CAD

K210666 · 510k · Jul 20, 2021

FractureDetect (FX)

K193417 · 510k · Jul 30, 2020

OsteoDetect

DEN180005 · De Novo · May 24, 2018

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

73% reduction of life-threatening clinical misses

Based on clinical research for Chest-CAD

100% increase in appropriate chronic disease identification

Based on Imagen customer impact

95% of physicians would recommend Imagen

Provider satisfaction

97% all-time customer retention rate

Customer satisfaction

96% patient satisfaction rate

Patient experience

100% expansion within customers to additional modalities & services

Customer growth

Imagen Customer Base

Improved chronic disease identification through AI-enabled imaging analytics

100% increase in appropriate chronic disease identification

Independent practices, hospitals, and health systems (aggregate)

Reducing life-threatening clinical misses and improving chronic disease identification through AI-enabled diagnostic imaging

73% reduction of life-threatening clinical misses and 100% increase in appropriate chronic disease identification

Provider organizations (aggregate customer satisfaction)

Delivering rapid, high-quality diagnostic imaging services with AI-enabled specialist interpretations

95% of physicians would recommend Imagen to other physicians, 97% all-time customer retention rate, 96% patient satisfaction rate

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

06 · Company updates

Updates from Imagen Technologies, Inc

Recent articles published on Imagen Technologies, Inc's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon